What We Do
Defective Medical Products
- Medicines
- Accutane Lawsuit
- AMO Complete Moistureplus Recall
- Apothecure Colchicine Lawsuit
- Baxter Heparin Recall and Lawsuit
- Bismacine Chromacine
- Botox
- Carbinoxamine
- Chromium Poisoning (Toxicity)
- Colchicine Recall Lawyer
- Colistimethate Lawsuit Lawyer
- Edetate Disodium
- Fentanyl
- Fentanyl Patch Recall
- Fentora
- Fleet Lawsuit - Phosphate Nephropathy
- Fosamax Osteonecrosis Jaw
- Ketek Liver Failure
- Ortho Evra Birth Control Patch
- Promethazine
- Rocephin Death
- Selenium Poisoning (Toxicity)
- Topical Anesthetic
- Total Body Formula Recall and Lawsuit
- Trasylol and Kidney Failure
- Trasylol - Lawyer and Lawsuit
- Trasylol Recall
- Tysabri Lawsuit - No Recall
- Zelnorm Heart Attack Stroke Lawsuit
- Medical Equipment
- Medtronic Defibrillator Leads
- Medtronic Lawsuit
- Medtronic Lawyer
- Guidant Recalls
- Free Guidant Recall Consultation
- Guidant Ancure
- Guidant Lawsuit Recall
- Guidant Pacemaker Defibrillator Defect
- Guidant Pacemaker Recall
- FDA Pacemaker Defibrillator Statement
- Infusion Pump
- FDA Recalls
- News & Topics
- Archives
Welcome to Pritzker | Ruohonen
Bismacine
Below is a FDA news release regarding the use of bismacine, also known as chromacine, an “alternative health” product that has been used to treat Lyme disease. The bismacine (chromacine) contains high amounts of bismuth and is injected into the patient. This can cause bismuth poisoning, which can lead to death or serious injury, including cardio-vascular collapse and kidney failure. Cardio-vascular collapse is “the sudden loss of consciousness due to failure of the heart to pump enough blood to the brain (2)." It is a life-threatening event. Pritzker | Ruohonen & Associates, P.A., a premier product liability law firm, is reprinting the FDA news release regarding bismacine (chromacine) and bismuth poisoning as a public service.
Lawyer Fred Pritzker has over 29 years of product liability lawsuit experience. He is a member of the American Board of Trial Advocates and the Million Dollar Advocates Forum. He has been selected by his peers for inclusion in the 2005-2006 edition of The Best Lawyers in America. To contact Pritzker | Ruohonen, call toll-free at 1-888-377-8900, e-mail info@pritzkerlaw.com, or fill out our online consultation form.
FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine
July 21, 2006 – The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromacine. The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine.
Bismacine is an injectable product that has been used to treat Lyme disease. But bismacine is not approved for anything, including Lyme disease.
Bismacine is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of "alternative health" or by people claiming to be medical doctors.
This product contains high amounts of bismuth, a heavy metal that is used in some medications taken by mouth to treat Helicobacter pylori (a bacteria that can cause stomach ulcers), but that is not approved in any form for use by injection.
On April 20, 2006, one person died as a result of treatment with bismacine, and on March 29, 2005, another person was hospitalized after receiving a bismacine treatment. Other individuals who have used or been administered this product have also suffered serious adverse events. Possible effects of bismuth poisoning include cardio-vascular collapse and kidney failure.
FDA is advising consumers and health care providers not to use bismacine. Individuals who believe they have suffered adverse events from receiving bismacine may wish to seek medical attention.
FDA is evaluating the product suppliers and will take additional action as appropriate.
Adverse reactions experienced with the use of this product should be reported to the FDA's MedWatch Adverse Event Reporting program online at www.fda.gov/MedWatch/report.htm, by phone (1-800-FDA-1088), or by returning the postage-paid FDA form 3500, which may be downloaded from www.fda.gov/MedWatch/getforms.htm, by mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 or fax (1-800-FDA-0178).
Sources:
- FDA news release regarding bismacine (chromacine), July 21, 2006, http://www.fda.gov/bbs/topics/NEWS/2006/
- Cardiovascular Collapse: Mechanisms of Individual Variability in Susceptibility to Syncope, Information on Levine Awards, http://www.ieemphd.com/current_awardsben.htm
Free Case Consultation
Firm News
Fred Pritzker Listed in The Best Lawyers in America
Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.
Pain and Suffering
Rich Ruohonen recently chaired a legal seminar on obtaining compensation for pain and suffering in a personal injury case. Rich uses his knowledge, experience, and reputation to maximize recoveries for clients.
Medtronic Recall and Medtronic Lawsuit
FDA has annonced a Medtronic Spring Fidelis defibrillator lead recall. Two of our clients with defective Medtronic leads were shocked over twenty times before medical professionals were able to turn off the defibrillator.
Fleet Lawsuit
We are representing several people who experienced kidney failure (acute phosphate nephropathy) after use of Fleet Phospho-soda solution or Fleet Accu-Prep solution for bowel cleansing.
Ortho Evra Lawsuit: Ortho Evra Birth Control Patch
The Ortho Evra birth control patch has been linked to an increased risk of blood clots that can lead to pulmonary embolism, stroke and heart attack.
Trasylol Recall
Bayer has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.
Fentanyl Lawsuit and Fentanyl Recall
There have been a number of recalls regarding fentanyl due to the risk of a fentanyl overdose.
Fosamax and Osteonecrosis
Several cases of bisphosphonate-associated osteonecrosis of the jaw have been associated with the use of oral bisphosphonates, including Fosamax®, Actonel®, and other medications.